Clinical Trial Update: Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating four-drug reinduction with bortezomib for relapsed or refractory acute lymphoblastic leukemia or lymphoblastic lymphoma in children and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: Children's Mercy Hospital Kansas City | Conditions: Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2019-08-13